MarketPulse
G

$GRTX

2 articles found
0 positive
1 negative
1 neutral
BenzingaBenzinga··Na

Galera and Obsidian Merge in All-Stock Deal, $350M Financing Fuels TIL Therapy Push

Galera and Obsidian merge in all-stock deal with $350M financing, creating Obsidian Therapeutics ($OBX) focused on TIL cell therapies with funding through 2028.
GRTXclinical trialsmerger agreement
GlobeNewswire Inc.GlobeNewswire Inc.··Juan Monteverde

Class Action Probe Targets Galera-Obsidian Merger Over Shareholder Dilution Concerns

Class action firm investigates Galera-Obsidian merger, alleging unfair terms as Galera shareholders face 1.8% combined-company ownership post-deal.
GRTXclass actionmerger investigation